1 / 13

Advanced Cancer Treatment Symposium: Scientific Presentations and Breakout Sessions

Join us for presentations on new technologies in cancer treatment, breakout group discussions led by experts, and summaries on opportunities and priorities. Explore key questions and guidelines in cancer care advancements.

wrachel
Download Presentation

Advanced Cancer Treatment Symposium: Scientific Presentations and Breakout Sessions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NCI: AT RO: SATURDAY Opportunities and Priorities • Presentations: 15 min or less • Breakout sessions • Summary & Conclusions & Feedback

  2. BREAKOUT GROUPS • Group 1 - Head (Brain, H&N & Peds) • Group 2 - Trunk (Breast, Lung & Upper Abd) • Group 3 - Pelvis (Prostate, Cervix & Colon-Rectum)

  3. GROUP 1 • Bharat Mittal: Leader • Kian Ang • Wally Curran • Tom Delaney • Jonathan Farr • Jim Galvin • Eric Hall • Ed Halperin • Larry Kun • Minesh Mehta • Tom Merchant

  4. GROUP 2 • Ted Deweese : Leader • Michael Baumann • Hank Choy • Joseph Deasy • Beryl McCormick • Nancy Mendenhall • Jatinder Palta • James Purdy • Randy Ten Haken • Allan Thornton • Jim Cox • Radhe Mohan

  5. GROUP 3 • Mary Gaspodarowicz & Jeff Michalski: Leaders • Chuck Enke • Thomas Fitzgerald • David Jaffray • David Gaffney • Karin Haustermans • Cliff Ling • Howard Sandler • Bill Shipley • Anurag Singh • Jerry Slater • Chris Willet

  6. My Take • Photons, Protons • IMRT, SRS, SBRT, IGRT • Quality Assurance • Image guidance • Lung cancer • Prostate cancer • Head & Neck Cancer • Peds

  7. GUIDELINES • Timer, Scribe and Presenter  • Limit comments to 2 minutes or less • Try to have everybody voice opinions • Please allow everybody around the table to voice opinions at least once before commenting second time, so on so forth • Discussion and formulation: 120 min. • Summary and mock presentation among your group:30 min. 

  8. KEY QUESTION 1 • The raison d’etre for the advanced technologies is to increase the dose to the cancer without increasing toxicity, or deliver the same dose as conventional technology but with less toxicity. QUESTION: In which cancers is there the most pressing need for new technology for increasing the dose or decreasing the toxicity?

  9. KEY QUESTION 2 • Demonstrating improved ANTICIPATED dose distributions (in-silico or in phantoms) only generates the hypothesis that a new technology may be superior. To prove that hypothesis, we must demonstrate - by controlled clinical trials - a clinically meaningful increase in survival and/or decrease in toxicity. QUESTION: What clinical trials are the most important for demonstrating a meaningful benefit to patients?

  10. KEY QUESTION 3 • Demonstrating improved ACTUAL dose distribution in the patient could be useful in phase I/II trials. QUESTION: What technological developments are required for demonstrating ACTUAL dose distribution in-vivo?

  11. KEY QUESTION 4 • Other clinical or biological intermediate end-points may be useful in clinical trials. QUESTION: What might those intermediate end-points be (and what lessons have we learned regarding their pitfalls from PSA, etc?)

  12. SUCCESSFUL MEETING • Do we clearly understand the objectives of the meeting? • Are we focusing on relevant facts and keeping to the original objectives? • Are we using our time efficiently? • Are we working towards solutions and results?

  13. SUMMARY, REC. & FEEDBACK • Each group presentation: 10 -15 min • Q & A: 15 min • Feedback: • Overall impression • Best part of the workshop • What would you do to improve this kind of workshop? • Rate the performance of this group

More Related